Emerging and seminal studies have shown that cell metabolism influences gene expression by modifying the epigenome, which can regulate stem cell pluripotency, differentiation, and somatic cell reprogramming. Core pluripotency factors and developmental regulators reciprocally control the expression of key metabolism genes and their encoded pathways. Recent technological advances enabling sensitive detection methods during early mammalian development revealed the state-specific and context-dependent coordination of signal transduction, histone modifications, and gene expression in developing, resting, and malnourished embryos. Here, we discuss metabolism as a potential driver of earliest cell fate through its influence on the epigenome and gene expression in embryos and their in vitro surrogate pluripotent stem cells.
Introduction
In its broadest sense, cellular metabolism is a dynamic orchestration of interconnected signaling networks involving the coordination of nutrient utilization to generate energy (ATP) and biomass as well as energy consumption and biomass removal and recycling. The importance of cell metabolism is straightforward in certain contexts, such as building biomass for cell proliferation, compared with less obvious contexts, such as during cell-state transitions driven by epigenetic remodeling and specific gene activation or suppression. There is rapidly accumulating evidence for extensive, interdependent interactions between metabolism and epigenetics in cancerous transformation (Kinnaird et al., 2016) , immune system activation and silencing (Raghuraman et al., 2016) , and now stem cell maintenance and differentiation (Ryall et al., 2015) . A robust example of concurrent changes in epigenome remodeling and cell proliferation occurs during early mammalian embryo development. Blastomeres formed by cleavage divisions do not grow and show minimal gene expression, which suddenly transitions to re-setting of the chromatin structure, massive genome transcription, protein translation, and increased cell proliferation following zygotic genome activation (ZGA) (Jukam et al., 2017) . After ZGA, additional changes in epigenetic and gene expression programs occur during pre-and post-implantation embryonic development.
Pluripotent stem cells (PSCs) model cells from pre-and postimplantation embryos and grow indefinitely in culture. They have garnered tremendous attention because of multiple potential applications. Biochemical, molecular, and functional features of PSCs, including metabolism, are being intensively studied. Similarities and distinctions between PSC metabolism and metabolic features from early-stage embryos reported more than 40 years ago are being revisited today with newer, small sample techniques (Leese, 2012) . This re-examination has practical consequences as investigators attempt to identify optimal ex vivo conditions for generating mature and functional cell types from PSC differentiation protocols.
In contrast to 40 years ago, today there are several types of cultured mammalian PSCs with differing developmental potential that resemble cells at different stages of early embryo development. ''Naive''-state PSCs functionally resemble the pre-implantation blastocyst inner cell mass with differentiation potential for all three germ layers and primordial germ cells. ''Primed''-state PSCs (Tesar et al., 2007; Brons et al., 2007) resemble post-implantation epiblast cells that have a low capacity to contribute to embryonic chimeras and a low competence for germline differentiation (Weinberger et al., 2016) . ''Extended'' PSCs can form both embryonic and extraembryonic tissues, reminiscent of early blastomeres (Yang et al., 2017) . A key challenge for studying early embryos are small sample sizes with limited starting materials. Fortunately, technological advances are beginning to provide versatile omics tools that can analyze the molecular features of small samples directly from early embryos (Lu et al., 2016; Wu et al., 2016; Xue et al., 2013) . Profiling studies are starting to reveal that metabolic programs are regulated by stage-specific transcription factors or other types of regulators and also that, reciprocally, metabolism may promote fate regulator expression in humans and mice. This new insight helps integrate metabolic patterns with upstream regulatory circuits and uncovers potential causal roles for specific aspects of metabolism that confer downstream cell-fate determination. Beyond development, epidemiologic studies on the pathological effects of parental and fetal malnutrition are increasingly being explored using small animal models (Sharma and Rando, 2017) . It is possible that understanding metabolism in early development will uncover mechanisms for diseases with embryonic origins and also linked malnutrition causes. In this Review, we evaluate, interpret, and discuss recent metabolic findings for embryos and for in vitro surrogate cultured PSCs. We further assess the current state of integration of metabolism into the PSC regulatory circuitry and its potential impact on cell fate with implications for malnutrition in embryo development and causal connections to adult diseases.
Metabolic Features of PSCs
Embryonic stem cells (ESCs) or induced pluripotent stem cells (iPSCs), collectively referred to as PSCs, are the most accessible cell types to study metabolic events in early mammalian development. Although valuable, PSC studies, nevertheless, may or may not represent the intrinsic metabolic features of their in vivo counterparts, as PSCs may acquire unique metabolic features to support infinite self-renewal in several types of culture conditions (Tang et al., 2010) . A decade ago, studies began revealing unique patterns of cellular metabolism during PSC differentiation (Chung et al., 2007) , during reprogramming to pluripotency (Folmes et al., 2011) , and in naive-versus primed-state PSCs (Zhou et al., 2012) . Combined, these studies showed a link between metabolic patterns and the loss, gain, or maintenance of PSC pluripotency.
In general, PSCs exhibit a high glycolytic flux to support high energy and biosynthetic demands during rapid proliferation (Folmes et al., 2011; Zhang et al., 2011) . These metabolic features are also reacquired during nucleus reprogramming of somatic cells to iPSCs prior to the induction of pluripotency gene expression (Folmes et al., 2011; Kida et al., 2015) . Robust metabolism in PSCs supports proliferation and metabolite production for epigenome modifications, as, for example, acetyl-CoA produced by glycolysis maintains histone acetylation and pluripotency (Moussaieff et al., 2015) . Naive-or more primitive-and primed-or developmentally more advanced-stages of pluripotency have been defined for mouse PSCs. Naive PSCs and primed epiblast stem cells (EpiSCs) are both metabolically active, but naive PSCs respire more than primed EpiSCs (Zhou et al., 2012) , which has been reviewed in detail previously (Teslaa and Teitell, 2015) . This metabolic pattern could support the production of the TCA cycle intermediates for amino acid biosynthesis and the mitochondrial folate cycle for nucleotide biosynthesis. Higher oxygen consumption through respiration is consistent with a slightly lower proliferation rate for naive PSCs because nutrient carbons may be lost as CO 2 to lessen the rate of biomass accumulation required for cell replication. Differences in mitochondrial metabolism between naive and primed PSCs likely foster large epigenome differences, such as global hypomethylation in naive PSCs and hypermethylation in primed PSCs, because metabolites serve as co-factors or substrates for epigenome-modifying enzymes, as discussed below. Clearly, there are additional effects from active mitochondria in naive PSCs that need further study and that go beyond support for growth and proliferation. Finally, recent work has also begun to examine metabolic remodeling linked to lineage-specific differentiation, which has refined the concept that differentiation from pluripotency always requires a shift from glycolytic to oxidative metabolism. Sustained high-level glycolysis without an oxidative shift through maintained expression of MYC/MYCN during ectoderm lineage differentiation contrasts with a shift to oxidative metabolism and MYC/MYCN repression for mesoderm and endoderm lineage differentiation (Cliff et al., 2017) .
Metabolism in Early Mammalian Embryos
In contrast to our increasing knowledge of cell metabolism in easily expandable PSCs, our understanding of metabolism in early mammalian embryos remains rudimentary and mostly based on whole-embryo nutritional needs (Brown and Whittingham, 1991) , metabolic activities (Acton et al., 2004; Houghton et al., 1996) , and the abundance of certain metabolites in whole embryos (Barbehenn et al., 1978) . Few studies have dissected embryonic metabolism with spatial or temporal resolution or by specific cell types, such as differences and similarities between trophectoderm and the blastocyst inner cell mass (Gopichandran and Leese, 2003; Houghton, 2006; Robinson and Benos, 1991) . Cultured PSCs are likely imperfect surrogates for in vivo counterparts within a developing embryo because microenvironment differences may cause variation in metabolism gene expression (Tang et al., 2010) , which limits our extrapolation of in vitro PSC results. New transcriptome profiling studies of individual cells from each stage of early embryo development and each lineage within an embryo are providing expression data for all genes, including metabolism-regulating genes. Concurrently, new epigenome profiling studies requiring just a few cells Zhang et al., 2016a) are providing potential mechanistic data for metabolism gene regulation and perhaps how certain environmental insults influence the epigenome at the earliest stages in mammalian development. A missing component for profiling technologies applied to embryogenesis is the metabolome, as current metabolomics and metabolic flux studies remain challenging for small numbers of cells.
Recent transcriptome and epigenome profiling has revealed clues for changes in metabolism during certain stages of early embryo development (Figure 1) . Two studies examining singlecell RNA transcriptomes of mouse and human pre-implantation embryos showed the induction of genes controlling OXPHOS during the blastocyst stage of development (Yan et al., 2013; Xue et al., 2013) . These results agree with prior studies that showed blastocysts consuming high levels of oxygen, most likely through mitochondrial respiration (Houghton et al., 1996; Leese, 2012) . They also align well with naive PSCs that resemble pre-implantation epiblast cells (Boroviak et al., 2015) showing active respiration (Zhou et al., 2012 Transcriptome studies of mammalian diapause embryos, and embryos deficient in mTOR or MYC that resemble diapause (Bulut-Karslioglu et al., 2016; Scognamiglio et al., 2016; Boroviak et al., 2015) , are providing new connections between metabolism and this physiologic dormant reproductive state. Naive ESCs deficient in both c-Myc and N-Myc enter a quiescent state with a strong reduction in protein and nucleic acid biosynthesis, similar to inhibition of MYC in blastocysts, which also induces a dormant state with reduced protein biosynthesis (Scognamiglio et al., 2016) . Inhibition of mTOR in ESCs caused global transcription repression, and inhibition of mTOR in blastocysts led to paused embryo development, similar to mammalian diapause (Bulut- Karslioglu et al., 2016) . Diapause embryos, with lower expression of c-Myc and N-Myc (Scognamiglio et al., 2016) , maintain naive epiblast gene expression patterns and also show lowered expression of glycolytic genes and serine metabolism genes, such as Aldoa and Phgdh (Boroviak et al., 2015) . Upstream inhibition of the one-carbon serine metabolism pathway might account for reductions in nucleotide biosynthesis, DNA/RNA metabolism, and lower proliferation in diapause (Locasale, 2013; Yang and Vousden, 2016) . Whether diapause also induces other one-carbon metabolism changes, such as in S-adenosylmethionine (SAM) production that could alter the methylation state of the epigenome, or changes in the cellular redox state mediated by glutathione is currently unknown. An additional regulator of pluripotency, LIN28, is an intermediate in the MYC to mTOR pathway. LIN28 expression can be induced by c-MYC (Chang et al., 2009) and is co-regulated by ERK/MEK signaling as both c-MYC and LIN28A proteins are phosphorylated and stabilized by ERK (Sears et al., 2000; Tsanov et al., 2017) . LIN28 also influences mTOR signaling by targeting IGF/PI3K/mTOR signaling pathway members through let-7 in mouse embryonic fibroblasts (Zhu et al., 2011) . Depletion of LIN28 in mouse ESCs also reduces one-carbon metabolism and nucleotide biosynthesis (Zhang et al., 2016b) , similar to MYC-depleted ESCs or mTOR-suppressed ESCs. LIN28 suppression in mouse zygotes arrests development between two-cell and four-cell stages (Vogt et al., 2012) , which is reminiscent of MYC or mTOR deficiency-caused embryo developmental dormancy. Whether this arrested transition is due to a metabolic deficiency alone, other gene regulatory network alteration, or both causes is currently unknown.
Remarkably, a subset of TCA cycle enzymes transiently localizes in the nucleus at the two-cell embryo stage in mice and between four-and eight-cell stages in human development, coincident with ZGA for each species, and seems to be critical for ongoing development (Nagaraj et al., 2017) . Pyruvate is a nutrient that is required to support the one-cell-to-morula transition in mice prior to glucose becoming an essential nutrient (Brown and Whittingham, 1991) . Interestingly, the nucleus localization of several TCA enzymes during the two-cell stage of development in mice is pyruvate dependent. Lack of pyruvate in the media of cultured mouse zygotes led to a two-cell stage arrest and a reduction in citrate and a-ketoglutarate (aKG), along with reduced H3K4Ac, H3K27Ac, and H3K27me3 epigenome marks and decreased global transcription activity. These data provide evidence for a specialized nucleus metabolic program during ZGA that is required for gene activation, likely through changes in the epigenome. The relationship between this metabolic program and waves of transcriptional activity during ZGA is currently unknown (Jukam et al., 2017) .
Pluripotency Circuitry and the Metabolic Network
Distinct patterns of metabolic activity associate with specific developmental stages and cell fates. This correlation suggests probable integration between the circuitry that controls pluripotency and early development and the regulation of metabolic gene expression and function (Figure 2 ). Accumulating evidence from PSC studies supports this suggestion. For example, to maintain or induce pluripotency, developmentally activated c-Myc directly trans-activates glycolysis genes (Folmes et al., 2013; Cao et al., 2015) . Also, development factor LIN28 regulates glycolysis by repressing let-7, which targets the glycolysis enzyme Pdk1 (Ma et al., 2014) and influences OXPHOS gene expression through post-translational mechanisms in mouse 
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The nutrient pyruvate supports the one-cell-to-morula transition in mice prior to glucose becoming an essential nutrient. Enzymatically active PDH and a subset of the TCA cycle enzymes transiently localize into the nucleus at the two-cell stage in mice and between four-and eight-cell stages in human development, coincident with ZGA for each species. Mitochondrial respiration activates during the mouse blastocyst stage and inactivates after implantation, around the same time blastocyst epiblast activation of OXPHOS genes occurs as revealed by transcriptome profiling, and is consistent with high mitochondrial activity in cultured naive-versus primed-state PSCs. PDH, pyruvate dehydrogenase; ZGA, zygotic gene activation.
ESCs (Zhang et al., 2016b) . Pluripotency-associated mir-290 cluster microRNAs in mouse ESCs activate glycolysis by repressing a reader for methylated CpG dinucleotides, MBD2, which represses c-Myc directly and glycolysis genes Pkm2 and Ldha (Cao et al., 2015) . The transcription factor ERR, which is a cofactor of PGC-1a that is transiently induced by somatic cell reprogramming with OSKM factors, generates a burst of OXPHOS activity at day 3 or 5 of mouse and human reprogramming, respectively (Kida et al., 2015) . Finally, a serine metabolism gene, Psat1, is trans-activated by core pluripotency factors Oct4/Sox2/Nanog and mediates the production and effects of aKG on mouse ESC differentiation (Hwang et al., 2016) . Combined, the evidence is strong and mounting that pluripotency and development factors coordinately regulate metabolic gene expression and activity in early mammalian development.
A transition between mouse PSC naive and primed states engages development factors Stat3, Esrrb, Zic3, and Lin28a/b and provides new details for how the metabolic network of these two pluripotent stages is regulated by this circuitry (Figure jFig. 2) (Sone et al., 2017; Zhang et al., 2016b; Carbognin et al., 2016) . For naive-state PSCs, Stat3 sustains the nucleus naive gene expression profile and also interacts with the mitochondrial genome to activate genes promoting respiration (Carbognin et al., 2016) . Esrrb induces OXPHOS through an unknown mechanism during the primed-to-naive-state transition, and it has a similar function during somatic cell reprogramming to pluripotency (Sone et al., 2017) . Esrrb and Zic3 synergistically enhance glycolysis during iPSC generation, and they combine to maintain pluripotency through direct binding of glycolysis promoting genes. Conversely, Lin28a/b represses OXPHOS to support state conversion in the opposite direction from the naive to primed state (Zhang et al., 2016b) , and Zic3 alone can repress OXPHOS and activate glycolysis to help establish the primedstate metabolic profile (Sone et al., 2017) . Collectively, these reports show that key metabolic parameters are controlled by state-specific pluripotency and development factors, strongly suggesting that metabolism has an active, required role in shaping different pluripotent states.
To what Extent Can Metabolism Influence PSC and Early Embryo Fates?
Changes in metabolism could passively participate in PSC and early embryo fate determination driven by other regulatory factors, or they could help shape and even control fate outcomes (Zhang et al., 2012) . Accumulating data strongly suggest an active role for metabolism in early cell-fate determination. Fateinfluencing mechanisms are centered on several key metabolism-regulating signal transduction pathways, such as AMPK/mTOR (Bulut-Karslioglu et al., 2016) , and intermediate metabolites, such as aKG, SAM, and acetyl-CoA (Ryall et al., 2015) (Figure 3 ). Changes in bioenergetics or nutrient availability resulting in a high ADP/ATP ratio inactivates the AMPK/mTOR pathway, as do mTOR inhibitors, and consequently stalls development similar to the physiologic diapause in rodent embryos (Bulut-Karslioglu et al., 2016) . Additionally, AMPK/mTOR pathway activity is also required for post-implantation proliferation of embryonic and extraembryonic cells in vivo (Murakami et al., 2004) . The TCA cycle metabolite aKG is a required co-factor for dioxygenase enzymes that include the Jumonji C (JmjC)-domain-containing histone demethylases (JHDMs) and Teneleven translocation (TET) DNA methylcytosine hydroxylases. aKG levels impact histone H3K9m3 and H3K27m3 marks to facilitate cell-fate outcomes between LIF/2i naive-state PSCs and a LIF/serum metastable PSC state (Carey et al., 2015) or FGF2/Activin-induced primed PSC state (Zhang et al., 2016b) . aKG levels can also promote PSC differentiation through altering histone Naive PSC factor ESRRB activates mitochondrial OXPHOS, and STAT3 binds to the mitochondrial genome to enhance oxidative metabolism. Primed PSC factor LIN28 coordinates with let-7 to enhance glycolysis and repress OXPHOS. Pluripotency core factors OCT4, NANOG, and SOX2 bind the serine metabolism Psat1 gene promoter to activate transcription and influence mouse ESC differentiation. Nuclear factor ESRRB activates OXPHOS and c-MYC activates glycolysis at early stages of somatic cell reprogramming to iPSCs to pre-set the metabolism program before induction of pluripotency gene expression. MYC and mTOR are required for anabolic metabolism in mouse ESCs and embryos, with loss of mTOR and MYC generating a dormant state that resembles reproductive diapause and maintains features of naive pluripotency. In the diagram, orange-colored objects are regulators associated with naive-state metabolism. Blue-colored objects depict regulators that, upon depletion, may confer mouse ESCs' naive-like state features. Gray-colored objects indicate regulators related to metabolism in maintenance of general pluripotency, differentiation, and reprogramming.
and DNA methylation levels in spontaneous mouse ESC differentiation (Hwang et al., 2016) and in directed human neuroectoderm differentiation (TeSlaa et al., 2016) even though the mechanisms of aKG production may vary in different cell contexts. Levels of the one-carbon metabolism pathway metabolite SAM influence H3K4me3 levels in mouse ESCs (Shyh- and in human ESCs (Shiraki et al., 2014) . Acetyl-CoA produced during glycolysis affects histone acetylation and gene expression in both human and mouse ESCs, and modulation of acetyl-CoA levels either by inhibiting glycolysis enzymes or by supplementing acetate influences PSC pluripotency versus differentiation fates (Moussaieff et al., 2015) . Key metabolites, including those that are produced intracellularly or those that are imported from the microenvironment or culture media, can substantially influence histone and/or DNA epigenetic marks. Nevertheless, our current understanding of how metabolic pathways influence cell fate is complicated by two unresolved challenges. One challenge is to provide evidence that the physiologic fluctuation of metabolite levels can cause significant changes of global or local chromatin modifications. Another challenge is to provide evidence that metabolism-mediated epigenetic changes can translate to specific changes in gene expression that are causal for cell-fate outcomes, which is briefly discussed below.
Interpreting the Influence of Metabolites on Epigenetics and Cell Fate
Studies to date provide relatively consistent and reinforcing data for interconnections between metabolite levels, epigenetic alterations, and fate outcomes for PSCs without resolving questions of specificity and causality. Which chromatin modifications during embryo development arise from differences in which metabolites? Which genes affected by metabolism-mediated changes in histone and/or DNA modifications are involved in cell-fate determination? Reporting correlations between metabolic rewiring, epigenetic modifications, gene expression, and cell fate is the status quo, and definitive studies showing that metabolism influences PSC fate through epigenetic alterations are still lacking. Direct evidence for causal connections and molecular mecha- nisms requires further studies with new tools and technologies, such as site-specific epigenetic modifiers that are under development to confer causality.
A second open area is to determine how much each nutrient source contributes to a metabolite pool of interest. This is a difficult question to address because it is technically infeasible to knock out all the genes controlling a specific metabolite, leaving extracellular metabolite addition or omission as the leading way to perturb some metabolites of interest. Also, metabolite pools arise from multiple sources, making assignments of nutrient origins potentially complex. For example, in PSCs, aKG originates from the TCA cycle via isocitrate dehydrogenase, from glutaminolysis through glutaminase (TeSlaa et al., 2016) , or from serine metabolism through phosphoserine aminotransferase (Hwang et al., 2016) . Also, SAM can be produced from exogenous or glucose-derived serine, from threonine metabolism in mouse ESCs , or from methionine metabolism in human ESCs (Shiraki et al., 2014) .
Another open question is evidence in vivo showing that metabolite levels control biochemical reactions to modify chromatin. For example, it has not been shown within a PSC nucleus that fluctuating aKG levels impact dioxygenase or demethylase enzyme activities. This would be difficult to do currently because, unlike in vitro biochemical reactions, there is no way to add or reduce only aKG without perturbing other systems within a cell. Similarly, a one-carbon subunit, such as a methyl group, from any nutrient source has not yet been shown to generate a methylation mark on a histone or deoxynucleotide. Therefore, development of new tools to monitor, quantify, and even manipulate specific metabolite levels within living cells will potentially provide causative links between changes in cell metabolism, the epigenome, and cell fate.
Embryo Malnutrition and Disease
Improved understanding of metabolism during embryonic development can lay a foundation for comparative studies of abnormal development due to environmental insults such as malnutrition. Malnutrition can predispose individuals to diseases that manifest later in life but whose origins begin during early development (Barker, 1997) . Studies using small animal models have revealed that poor nutrition may impact germ cells, and this information can be transmitted between generations and show up as changes in epigenetic modifications and/or the expression of small noncoding RNAs Huypens et al., 2016; Sharma et al., 2016) , as recently reviewed (Sharma and Rando, 2017) . It is technically more difficult to tease out maternal effects of malnutrition for studies on early embryo development because placental insufficiency or hormone deregulation can also be caused by malnutrition in a pregnant female. In addition to malnutrition models, genetics studies are also useful. There is evidence that the consequences of malnutrition in the unborn depend upon genetic polymorphisms in IGF2BP2 and PPAR-g2 from the Dutch Famine Birth Cohort (van Hoek et al., 2009; de Rooij et al., 2006) . Therefore, genetic manipulations of key metabolism-related genes may help to model fetal malnutrition in animals, and such models can be potentially disentangled from maternal effects. For example, conditional knockout of Lin28a and Lin28b in embryos using tamoxifen-induced excision can cause aberrations in growth and glucose metabolism in adults (Shinoda et al., 2013) . Since most metabolism genes are ubiquitously expressed and required for normal adult tissue development and physiology, transient reduction of these genes during embryo development may be preferable for modeling effects of transient malnutrition in utero. For instance, with an inducible dCAS9 fused to an activating or repressive domain, it is possible to transiently change a metabolism gene in the embryo, then determine acute metabolic alterations, and later determine long-term adult phenotype abnormalities and epigenome changes after the animal grows up. Once an animal model is established, critical questions can be asked, such as how a malnutrition signal is translated to long-lasting epigenetic memories that can be manifested in adult life, or even in the next generation.
Concluding Remarks
Great advances in our understanding of metabolism in PSCs have been made, with next steps to understand upstream regulators and downstream impact that are directly hard wired into PSC fates. Additionally, there are tremendous opportunities to understand metabolism in the physiological context of early embryo development, and in the pathological context of malnutrition and the early origins of diseases.
